These results indicated that the inhibition of Nrf2 transcriptional activity by ML385 significantly blocked the promotion of miR-141-3p on ferroptosis resistance and paclitaxel resistance in breast cancer cells. This evidence concerns the gene NFE2L2 and breast cancer.